Intuitive Surgical Inc. has received clearance from the U.S. Food and Drug Administration (FDA) to expand the indications for its da Vinci Single Port (SP) surgical system. The new FDA clearance allows the use of the da Vinci SP system for inguinal hernia repair, cholecystectomy, and appendectomy procedures. This expansion builds on the system's existing U.S. clearances for urology, colorectal, thoracic, and transoral surgeries, further broadening the scope of minimally invasive procedures that can be performed with the da Vinci SP platform.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intuitive Surgical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9600316-en) on December 10, 2025, and is solely responsible for the information contained therein.
Comments